Ameritas Advisory Services’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$8.63K	Buy	+300	New	+$8.63K	﹤0.01%	2072
2023 Q2	–	Sell	-300	Closed	-$5.7K	–	943
2023 Q1	$5.7K	Buy	+300	New	+$5.7K	﹤0.01%	2112